CODX vs MGM · rev $3.9M vs P/E 64, rev $17.54B
Co-Diagnostics, Inc. Common Stock (CODX) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported MGM revenue for 2025-12-31 was $17.54B. Net income was $205.9M. Revenue was up 1.7% from 2024-12-31 to 2025-12-31. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
CODX currently screens at market cap $31.4M. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the CODX and MGM stock pages for the full models.
Not investment advice.